Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Demyelination and other neurological adverse events after anti-TNF therapy.
Multiple sclerosis: A distinct disease course for paediatric multiple sclerosis.
Does HLA Class II Haplotype play a role in Adult Acute Disseminated Encephalomyelitis? Preliminary Findings from a Southern Italy hospital-based study.
Bevacizumab Diminishes Experimental Autoimmune Encephalomyelitis by Inhibiting Spinal Cord Angiogenesis and Reducing Peripheral T-Cell Responses.
Vitamin B(12) in neurology and ageing; Clinical and genetic aspects.
Structural and Metabolic Features of Two Different Variants of Multiple Sclerosis: A PET/MRI Study.
Signalling Pathways that Inhibit the Capacity of Precursor Cells for Myelin Repair.
High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.
[2012: news in neurology].
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis.
Grey matter lesions in MS: From histology to clinical implications.
Future treatment approaches to multiple sclerosis.
FDA Approves New Drug to Treat Psoriasis
ISENTRESS® prescribing information
Data supporting Arf6 regulation of Schwann cell differentiation and myelination.
Multiple Sclerosis and CCSVI: A Population-Based Case Control Study.
The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis.
Promoting physical activity to control multiple sclerosis from childhood.
Role of vitamin D in regulating the neural stem cells of mouse model with multiple sclerosis.
Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis.
Idiopathic inflammatory demyelinating diseases of the brainstem.
Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.
Progress of mesenchymal stem cell therapy for neural and retinal diseases.

Pages